CellaVision Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Simon Ostergaard
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.2yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO
Simon Ostergaard (54 yo)
Mr. Simon Ostergaard has been the Chief Executive Officer and President at CellaVision AB (publ) since March 21, 2021. He has broad experience is primarily in CellaVision's adjacent area of pathology and o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | no data | SEK 285.00k | 7.25% $ 27.2m | |
| CEO & President | 5yrs | no data | 0.021% $ 78.8k | |
| Chief Financial Officer | 1.2yrs | no data | no data | |
| Corporate Communications & Investor Relations | 1.2yrs | no data | no data | |
| Vice President of Business Development & Global Marketing | no data | no data | 0.013% $ 47.3k | |
| Vice President of Global Sales | 4.2yrs | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data |
Experienced Management: CLVS.F's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | 32.2yrs | SEK 285.00k | 7.25% $ 27.2m | |
| Independent Chairman of the Board | 6.2yrs | SEK 800.00k | 0.0099% $ 37.2k | |
| Employee Representative Director | 1.2yrs | no data | no data | |
| Independent Director | 7.8yrs | SEK 260.00k | no data | |
| Independent Director | less than a year | no data | no data | |
| Employee Representative Director | 6.2yrs | no data | no data | |
| Independent Director | 3.8yrs | SEK 398.00k | no data | |
| Independent Director | 2.8yrs | SEK 260.00k | no data |
Experienced Board: CLVS.F's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/20 11:02 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CellaVision AB (publ) is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bjorn Rydell | ABG Sundal Collier Sponsored |
| Carl-Oscar Bredengen | Berenberg |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |